Related Experiment Videos

The US Food and Drug Administration's expedited approval programs: Addressing premarket flexibility with enhanced

Joshua D Wallach1, Joseph S Ross2, Huseyin Naci3

  • 11 Collaboration for Research Integrity and Transparency, Yale School of Medicine, New Haven, CT, USA.

Clinical Trials (London, England)
|June 7, 2018
PubMed
Abstract

No abstract available in PubMed .

Keywords:
The US Food and Drug Administrationdrug policyexpedited approvalpharmaceutical regulationpostmarketing requirements

Related Concept Videos